These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16566296)

  • 1. Engineered protein inhibitors of proteases.
    Nixon AE; Wood CR
    Curr Opin Drug Discov Devel; 2006 Mar; 9(2):261-8. PubMed ID: 16566296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards the control of intracellular protein turnover: mitochondrial Lon protease inhibitors versus proteasome inhibitors.
    Bayot A; Basse N; Lee I; Gareil M; Pirotte B; Bulteau AL; Friguet B; Reboud-Ravaux M
    Biochimie; 2008 Feb; 90(2):260-9. PubMed ID: 18021745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic protease inhibitors as novel therapeutic agents.
    Scott CJ; Taggart CC
    Biochimie; 2010 Nov; 92(11):1681-8. PubMed ID: 20346385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia.
    Swedberg JE; de Veer SJ; Harris JM
    Biol Chem; 2010 Apr; 391(4):357-74. PubMed ID: 20180638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting proteases: successes, failures and future prospects.
    Turk B
    Nat Rev Drug Discov; 2006 Sep; 5(9):785-99. PubMed ID: 16955069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of proteolysis and other posttranslational modifications with substrate-targeted inhibitors.
    Kodadek T
    Biopolymers; 2002; 66(2):134-40. PubMed ID: 12325163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malarial protease inhibitors: potential new chemotherapeutic agents.
    Sharma A
    Curr Opin Investig Drugs; 2007 Aug; 8(8):642-52. PubMed ID: 17668366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
    Doucet A; Overall CM
    Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bauhinia Kunitz-type proteinase inhibitors: structural characteristics and biological properties.
    Oliva ML; Sampaio UM
    Biol Chem; 2008 Aug; 389(8):1007-13. PubMed ID: 18754727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking of protease allergens with inhibitors reduces allergic responses in allergic rhinitis and other allergic diseases.
    Suzuki M; Itoh M; Ohta N; Nakamura Y; Moriyama A; Matsumoto T; Ohashi T; Murakami S
    Acta Otolaryngol; 2006 Jul; 126(7):746-51. PubMed ID: 16803715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of protease inhibitors on exflagellation in Plasmodium falciparum.
    Rupp I; Bosse R; Schirmeister T; Pradel G
    Mol Biochem Parasitol; 2008 Apr; 158(2):208-12. PubMed ID: 18243365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of tissue kallikrein inhibitors: importance in cancer.
    Bhoola KD; Misso NL; Naran A; Thompson PJ
    Curr Opin Investig Drugs; 2007 Jun; 8(6):462-8. PubMed ID: 17621876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAFIa inhibitors in the treatment of thrombosis.
    Bunnage ME; Owen DR
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):480-6. PubMed ID: 18600565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel therapeutic target in various lung diseases: airway proteases and protease-activated receptors.
    Sokolova E; Reiser G
    Pharmacol Ther; 2007 Jul; 115(1):70-83. PubMed ID: 17532472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.
    Njoroge FG; Chen KX; Shih NY; Piwinski JJ
    Acc Chem Res; 2008 Jan; 41(1):50-9. PubMed ID: 18193821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of secreted protease inhibitors after water stress in potato tubers.
    Ledoigt G; Griffaut B; Debiton E; Vian C; Mustel A; Evray G; Maurizis JC; Madelmont JC
    Int J Biol Macromol; 2006 May; 38(3-5):268-71. PubMed ID: 16631926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [VI Symposium on "Chemistry of Proteolytic Enzymes"].
    Rumsh LD; Rotanova TV
    Bioorg Khim; 2008; 34(3):293-4. PubMed ID: 18672674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors from several classes work synergistically against Callosobruchus maculatus.
    Amirhusin B; Shade RE; Koiwa H; Hasegawa PM; Bressan RA; Murdock LL; Zhu-Salzman K
    J Insect Physiol; 2007 Jul; 53(7):734-40. PubMed ID: 17482206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic changes of proteases and protease inhibitors revealed by microarray analysis in CA3 and entorhinal cortex during epileptogenesis in the rat.
    Gorter JA; Van Vliet EA; Rauwerda H; Breit T; Stad R; van Schaik L; Vreugdenhil E; Redeker S; Hendriksen E; Aronica E; Lopes da Silva FH; Wadman WJ
    Epilepsia; 2007; 48 Suppl 5():53-64. PubMed ID: 17910582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family.
    Wang SX; Pandey KC; Scharfstein J; Whisstock J; Huang RK; Jacobelli J; Fletterick RJ; Rosenthal PJ; Abrahamson M; Brinen LS; Rossi A; Sali A; McKerrow JH
    Structure; 2007 May; 15(5):535-43. PubMed ID: 17502099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.